Patient Leaflet Updated 17-Jan-2024 | Dexcel Pharma Ltd
Deximune 25mg, 50mg, 100mg Soft Capsules
Deximune® 25 mg soft capsules
Deximune® 50 mg soft capsules
Deximune® 100 mg soft capsules
(Ciclosporin)
1. What Deximune is and what it is used for
2. What you need to know before you take Deximune
3. How to take Deximune
4. Possible side effects
5. How to store Deximune
6. Contents of the pack and other information
The name of your medicine is Deximune. It contains the active substance ciclosporin. This belongs to a group of medicines known as immunosuppressive agents. These medicines are used to lower the body’s immune reactions.
If you are taking Deximune following a transplant it will only be prescribed for you by a doctor with experience in transplants and/or autoimmune diseases.
The advice in this leaflet may vary depending on whether you are taking the medicine for a transplant or for an autoimmune disease.
Follow all your doctor’s instructions carefully. They may differ from the general information contained in this leaflet.
Do not take Deximune and tell your doctor if the above applies to you. If you are not sure, talk to your doctor before taking Deximune.
Before and during treatment with Deximune, tell your doctor straight away:
If any of the above applies to you before or during treatment with Deximune, tell your doctor straight away.
Deximune suppresses your immune system. This increases your risk of developing cancers, particularly of the skin and lymphoid system. You should limit your exposure to sunlight and UV light by:
If any of the above apply to you (or you are not sure), tell your doctor before taking Deximune. This is because this medicine contains an ingredient which is broken down into alcohol (see section below “Deximune contains ethyl lactate”).
Your doctor will check:
If you have any questions about how Deximune works or why this medicine has been prescribed for you, ask your doctor.
In addition, if you are taking Deximune for a non-transplant disease (intermediary or posterior uveitis and Behçet's uveitis, atopic dermatitis, severe rheumatoid arthritis or nephrotic syndrome), do not take Deximune:
Do not take Deximune if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Deximune.
If you are being treated for Behçet`s uveitis, your doctor will monitor you particularly carefully if you have neurological symptoms (for example: increased forgetfulness, personality changes noticed over time, psychiatric or mood disorders, burning sensation in limbs, decreased sensation in limbs, tingling sensation in limbs, weakness of limbs, walking disturbances, headache with or without nausea and vomiting, vision disturbances including restricted movement of eyeball).
Your doctor will closely monitor you if you are elderly and are being treated for psoriasis or atopic dermatitis. If you have been prescribed Deximune to treat your psoriasis or atopic dermatitis, you must not be exposed to any UVB-rays or phototherapy during treatment.
Deximune should not be given to children for a non-transplant disease, except for treatment of nephrotic syndrome.
There is limited experience with Deximune in elderly patients. Your doctor should monitor how well your kidneys work. If you are over 65 and have psoriasis or atopic dermatitis, you should only be treated with Deximune if your condition is particularly severe.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines before or during Deximune treatment:
If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist before taking Deximune.
Do not take Deximune with grapefruit or grapefruit juice. This is because these can affect how Deximune works. Deximune Capsules can be taken with or without food.
Ask your doctor or pharmacist for advice before taking this medicine.
Tell your doctor if you have hepatitis C. Your liver function may change with treatment of hepatitis C and this may affect the levels of ciclosporin in your blood. Your doctor may need to closely monitor ciclosporin blood levels and make adjustments to the dose after you start treatment for hepatitis C.
You may feel sleepy, disoriented, or have blurred vision after taking Deximune. Be careful driving or operating machinery while you are taking Deximune until you know how it affects you.
Deximune contains ethyl lactate that changes into ethanol (alcohol) and lactic acid in your gastrointestinal tract. Each Deximune 25 mg, 50 mg and 100 mg capsule contains 32 mg, 65 mg and 129 mg alcohol, respectively, which is equivalent to 14.2% v/v.
A 500 mg dose of Deximune contains a quantity of alcohol that is equivalent to approximately 17 ml beer or 7 ml wine. The small amount of alcohol in this medicine will not have any noticeable effects.
Deximune contains lecithin from soya. If you are allergic to peanut or soya, do not use this medicine.
Deximune contains macrogolglycerol hydroxystearate. It may cause stomach upset and diarrhoea.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Do not take more than the recommended dose.
The dose of this medicine will be carefully adjusted to your individual needs by your doctor. Too much of the medicine can affect your kidneys. You will have regular blood tests and visits to the hospital, especially after a transplant. This will give you the chance to talk to your doctor about your treatment and talk about any problems you may be having.
Your doctor will work out the correct dose of Deximune for you. This depends on your body weight and what you are taking the medicine for. Your doctor will also tell you how often to take your medicine.
Organ, bone marrow and stem cell transplantation
Endogenous uveitis
Nephrotic syndrome
Severe rheumatoid arthritis
Psoriasis and atopic dermatitis
Nephrotic syndrome
Follow your doctor's instructions exactly and never change the dose yourself, even if you feel well.
After you change from one oral formulation of ciclosporin to another:
Take Deximune at the same time every day. This is very important if you have had a transplant.
Your daily doses should always be taken in 2 divided doses.
Remove the capsules from the blister. Swallow the capsules whole with water.
Your doctor will tell you how long you need to take Deximune for. This depends on whether you are taking it after a transplant or for the treatment of a severe skin condition, rheumatoid arthritis, uveitis or nephrotic syndrome. For severe rash, the treatment usually lasts for 8 weeks.
Keep taking Deximune for as long as your doctor tells you.
If you have questions about how long to take Deximune, talk to your doctor or your pharmacist.
If you accidentally take too much of your medicine, tell your doctor immediately or go to your nearest hospital emergency unit. You may need medical attention.
Do not stop taking Deximune unless your doctor tells you to.
Keep taking Deximune even if you feel well. Stopping your treatment with Deximune may increase the risk of your transplanted organ being rejected.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor straight away if you notice any of the following serious side effects:
Very common: may affect more than 1 in 10 people.
If any of these affects you severely, tell your doctor.
Common: may affect up to 1 in 10 people.
If any of these affects you severely, tell your doctor.
Uncommon: may affect up to 1 in 100 people.
If any of these affects you severely, tell your doctor.
Rare: may affect up to 1 in 1,000 people.
If any of these affects you severely, tell your doctor.
Very rare: may affect up to 1 in 10,000 people.
If this affects you severely, tell your doctor.
Not known: Frequency cannot be estimated from the available data.
If any of these affects you severely, tell your doctor.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
There are no additional side effects to be expected in children and adolescents compared to adults.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website:
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Deximune soft capsules are available in 3 strengths containing 25 mg, 50 mg or 100 mg of the active substance, ciclosporin.
All capsule strengths contain the following other ingredients: polysorbate 20, sorbitan oleate, lecithin from soya, triglyceride, macrogolglycerol hydroxystearate, ethyl lactate.
Ingredients of the capsule shell: gelatin, glycerol, ferric oxide black (E172), titanium dioxide (E171).
Deximune 25 mg soft capsules are grey, opaque, oval, soft gelatin capsules (approximate dimensions: 8 mm width, 12 mm length). Deximune 50 mg soft capsules are grey, opaque, oblong, soft gelatin capsules (approximate dimensions: 8 mm width, 19 mm length). Deximune 100 mg soft capsules are grey, opaque, oblong, soft gelatin capsules (approximate dimensions: 10 mm width, 24 mm length). There are 30, 50 or 60 capsules in a pack. Not all pack sizes may be available.
This leaflet was last revised in December 2023.
Deximune is a registered Trade Mark.
7, Sopwith Way, Drayton Fields, Daventry, Northamptonshire, NN11 8PB, UK
+44 (0)1327 312 262
+44 (0) 1748 828 784
+44 (0) 1748 828 784
+44 (0)1327 312 266
http://www.dexcelpharma.com